{A figure is presented}An Enteric-Coated High-Buffered Pancrelipase Reduces Steatorrhea in Patients with Cystic Fibrosis: A Prospective, Randomized Study

Journal of the American Dietetic Association

Volumn 106, Issue 8, 2006, Pages 1181-1186

  Brady, Mary Sue ^a   Garson, Jennifer L ^a   Krug, Susan K ^a   Kaul, Ajay ^a   Rickard, Karyl A ^a   Caffrey, Helena Hoen ^a   Fineberg, Naomi ^a   Balistreri, William F ^a   Stevens, John C ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

GASTROINTESTINAL AGENT; MICROSPHERE; PANCRELIPASE;

ADOLESCENT; ADULT; ARTICLE; CHEMISTRY; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; CYSTIC FIBROSIS; DRUG EFFECT; ENTERIC COATED TABLET; ENZYMOLOGY; FAT INTAKE; FECES; FEMALE; HUMAN; INTESTINE ABSORPTION; MALE; METABOLISM; MULTICENTER STUDY; PANCREAS EXOCRINE INSUFFICIENCY; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; STATISTICAL MODEL; STEATORRHEA; TREATMENT OUTCOME;

ADOLESCENT; ADULT; CHILD; CROSS-OVER STUDIES; CYSTIC FIBROSIS; DIETARY FATS; EXOCRINE PANCREATIC INSUFFICIENCY; FECES; FEMALE; GASTROINTESTINAL AGENTS; HUMANS; INTESTINAL ABSORPTION; LINEAR MODELS; MALE; MICROSPHERES; PANCRELIPASE; PROSPECTIVE STUDIES; STEATORRHEA; TABLETS, ENTERIC-COATED; TREATMENT OUTCOME;

EID: 33746089930     PISSN: 00028223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jada.2006.05.011     Document Type: Article

References (31)

1. Brady M.S., Rickard K., Yu P.L., and Eigen H. Effectiveness and safety of small vs large doses of enteric coated pancreatic enzymes in reducing steatorrhea in children with cystic fibrosis. A prospective randomized study. Pediatr Pulm 10 (1991) 79-85
2. FitzSimmons S.C., Burkhart G.A., Borowitz D., Grand R.J., Hammerstrom T., Durie P.R., Lloyd-Still J.D., and Lowenfels A.B. High-dose pancreatic-enzyme supplements and fibrosing colonopathy in children with cystic fibrosis. N Engl J Med 336 (1997) 1283-1289
3. Stevens J., Maguiness K.M., Hollingsworth J., Heilman D.K., and Chong S.K.F. Pancreatic enzyme supplementation in cystic fibrosis patients before and after fibrosing colonopathy. J Pediatr Gastroenterol Nutr 26 (1998) 80-84
4. Smyth R.L., Ashby D., O'Hea U., Burrows E., Lewis P., van Velzen D., and Dodge J.A. Fibrosing colonopathy in cystic fibrosis. Results of a case control study. Lancet 346 (1995) 1247-1251
5. Borowitz D.S., Grand R.J., and Durie P.R. Use of pancreatic enzyme supplements for patients with cystic fibrosis in the context of fibrosing colonopathy. Consensus Committee. J Pediatr 127 (1995) 681-684
6. Kopelman H., Corey M., Gaskin D., Durie P., Weizman Z., and Forstner G. Impaired chloride secretion, as well as bicarbonate secretion, underlies the fluid secretory defect in the cystic fibrosis pancreas. Gastroenterology 95 (1988) 349-355
7. Soleimani M. Impaired pancreatic ductal bicarbonate secretion in cystic fibrosis. J Pancreas 2 suppl 4 (2001) 237-242
8. Youngberg C.A., Berardi R.R., Howatt W.F., Hyneck M.L., Amidon G.L., Meyer J.H., and Dressman J.B. Comparison of gastrointestinal pH in cystic fibrosis in healthy subjects. Dig Dis Sci 32 (1987) 472-480
9. Lemire S., and Iber F.L. Gastric inactivation of pancreatic supplements. Gastroenterology 48 (1965) 831
10. Proesmans M., and DeBoeck K. Omeprazole, a proton pump inhibitor, improves residual steatorrhea in cystic fibrosis patients treated with high dose pancreatic enzymes. Eur J Pediatr 162 (2003) 760-763
11. Hendriks J.J.E., Kester A.D.M., Donckerwolcke R., Forget P.P., and Wouters E.F.M. Changes in pulmonary hyperinflation and bronchial hyperresponsiveness following treatment with lansoprazole in children with cystic fibrosis. Pediatr Pulm 31 (2001) 59-66
12. Robinson P., and Sly P.D. Placebo-controlled trial of misoprostol in cystic fibrosis. J Pediatr Gastroenterol Nutr 11 (1990) 37-40
13. 1 analogue (misoprostol) as an adjunct to pancreatic enzymes replacement in cystic fibrosis. Scand J Gastroenterol 23 suppl 143 (1988) 142-147
14. Durie P.A., Bell L., Linton W., Corey M.L., and Forstner G.G. Effect of cimetidine and sodium bicarbonate of pancreatic replacement therapy in cystic fibrosis. Gut 21 (1980) 778-786
15. Graham D.Y. Adjuvant therapy in pancreatic exocrine insufficiency. Gastroenterology 83 (1982) 1147-1148
16. ®. US Patent 5,750,104. May 12, 1998.
17. Gibson L.E., and Cooke R.E. A test for concentration of electrolytes in sweat in cystic fibrosis of the pancreas utilizing pilocarpine by iontophoresis. Pediatrics 18 (1959) 545-549
18. Borowitz D., Durie P.R., Clark L.L., Werlin S.L., Taylor C.J., Semler J., De Lisle R.C., Lewindon P., Lichtman S.M., Sinaasappel M., Baker R.D., Baker S.S., Verkade H.J., Lowe M.E., Stallings V.A., Janghorbani M., Butler R., and Heubi J. Gastrointestinal outcomes and confounders in cystic fibrosis. J Pediatr Gastroenterol Nutr 41 (2005) 273-285
19. Borowitz D., Baker R.D., and Stallings V. Consensus report on nutrition for pediatric patients with cystic fibrosis. J Pediatr Gastroenterol Nutr 35 (2002) 246-259
20. Zhang S., and Lai H.J. Malnutrition screening in children with CF. Am J Clin Nutr 80 (2004) 982-991
21. Brady M.S., Rickard K., Yu P.L., and Eigen H. Effectiveness of enteric coated pancreatic enzymes given before meals in reducing steatorrhea in children with cystic fibrosis. J Am Diet Assoc 92 (1992) 813-817
22. Fomon S.J. Appendix. In: Fomon S.J. (Ed). Nutrition of Normal Infants (1993), Mosby, St Louis, MO 463-464
23. Ellefson R.D., and Caraway W.T. Lipids and lipoproteins. In: Tietz N.W. (Ed). Fundamentals of Clinical Chemistry. 2nd ed. (1976), WB Saunders, Philadelphia, PA 474-541
24. van de Kamer J.H., Huinick H., and Weyers H.A. Rapid method for determination of fat in feces. J Biol Chem 177 (1949) 347-355
25. Institute of Medicine, Food and Nutrition Board. Dietary Reference Intakes. Energy, Carbohydrate, Fiber, Fat, Fatty Acids, Cholesterol, Protein, and Amino Acids (2002), National Academy Press, Washington, DC
26. Dressman J.B., Shtohryn L.V., and Diokno D. Formulation effects on pancreatic performance in vitro. Am J Hosp Pharm 42 (1985) 2502-2506
27. Kalnins D., Ellis L., Corey M., Pencharz P.B., Stewart C., Tullis E., and Durie P. Enteric-coated pancreatic enzymes with bicarbonate is equal to standard enteric-coated enzyme in treating malabsorption in cystic fibrosis. J Pediatr Gastroenterol Nutr 42 (2006) 256-261
28. Corey M., McLaughlin F.J., Williams M., and Levison H. A comparison of survival, growth, and pulmonary function in patients with cystic fibrosis in Boston and Toronto. J Clin Epidemiol 41 (1988) 583-591
29. Sharma R., Florea V.G., Bolger A.P., Doehner W., Florea N.D., Coats A.J., Hodson M.E., Anker S.D., and Henein M.Y. Wasting as an independent predictor of mortality in patients with cystic fibrosis. Thorax 56 (2001) 746-750
30. Thomson M.A., Quirk P., Swanson C.E., Thomas B.J., Holt T.L., Francis P.J., and Shepherd R.W. Nutritional growth retardation is associated with defective lung growth in cystic fibrosis. A preventable determinant of progressive pulmonary dysfunction. Nutrition 11 (1995) 350-354
31. Beker L.T., Russek-Cohen E., and Fink R.J. Stature as a prognostic factor in cystic fibrosis survival. J Am Diet Assoc 101 (2001) 438-442